These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36996258)
1. A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)-Study protocol. Penfold S; Adegnika AA; Asogun D; Ayodeji O; Azuogu BN; Fischer WA; Garry RF; Grant DS; Happi C; N'Faly M; Olayinka A; Samuels R; Sibley J; Wohl DA; Accrombessi M; Adetifa I; Annibaldis G; Camacho A; Dan-Nwafor C; Deha ARE; DeMarco J; Duraffour S; Goba A; Grais R; Günther S; Honvou ÉJJP; Ihekweazu C; Jacobsen C; Kanneh L; Momoh M; Ndiaye A; Nsaibirni R; Okogbenin S; Ochu C; Ogbaini E; Logbo ÉPMA; Sandi JD; Schieffelin JS; Verstraeten T; Vielle NJ; Yadouleton A; Yovo EK; PLoS One; 2023; 18(3):e0283643. PubMed ID: 36996258 [TBL] [Abstract][Full Text] [Related]
2. Emerging trends in Lassa fever: redefining the role of immunoglobulin M and inflammation in diagnosing acute infection. Branco LM; Grove JN; Boisen ML; Shaffer JG; Goba A; Fullah M; Momoh M; Grant DS; Garry RF Virol J; 2011 Oct; 8():478. PubMed ID: 22023795 [TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study. Grant DS; Engel EJ; Roberts Yerkes N; Kanneh L; Koninga J; Gbakie MA; Alhasan F; Kanneh FB; Kanneh IM; Kamara FK; Momoh M; Yillah MS; Foday M; Okoli A; Zeoli A; Weldon C; Bishop CM; Zheng C; Hartnett J; Chao K; Shore K; Melnik LI; Mucci M; Bond NG; Doyle P; Yenni R; Podgorski R; Ficenec SC; Moses L; Shaffer JG; Garry RF; Schieffelin JS PLoS Negl Trop Dis; 2023 Feb; 17(2):e0010938. PubMed ID: 36758101 [TBL] [Abstract][Full Text] [Related]
5. Animal Model of Sensorineural Hearing Loss Associated with Lassa Virus Infection. Yun NE; Ronca S; Tamura A; Koma T; Seregin AV; Dineley KT; Miller M; Cook R; Shimizu N; Walker AG; Smith JN; Fair JN; Wauquier N; Bockarie B; Khan SH; Makishima T; Paessler S J Virol; 2015 Dec; 90(6):2920-7. PubMed ID: 26719273 [TBL] [Abstract][Full Text] [Related]
6. Lesson learned from the investigation and response of Lassa fever outbreak, Margibi County, Liberia, 2018: case report. Woyessa AB; Maximore L; Keller D; Dogba J; Pajibo M; Johnson K; Saydee E; Monday J; Tuopileyi R; Mahmoud N BMC Infect Dis; 2019 Jul; 19(1):610. PubMed ID: 31296177 [TBL] [Abstract][Full Text] [Related]
7. Severe Human Lassa Fever Is Characterized by Nonspecific T-Cell Activation and Lymphocyte Homing to Inflamed Tissues. Port JR; Wozniak DM; Oestereich L; Pallasch E; Becker-Ziaja B; Müller J; Rottstegge M; Olal C; Gómez-Medina S; Oyakhliome J; Ighodalo Y; Omomoh E; Olokor T; Adomeh DI; Asogun D; Ogbani-Emovon E; Hartmann K; Krasemann S; Nelson EV; Escudero-Pérez B; McElroy AK; Günther S; Muñoz-Fontela C J Virol; 2020 Oct; 94(21):. PubMed ID: 32817220 [TBL] [Abstract][Full Text] [Related]
8. Current research for a vaccine against Lassa hemorrhagic fever virus. Warner BM; Safronetz D; Stein DR Drug Des Devel Ther; 2018; 12():2519-2527. PubMed ID: 30147299 [TBL] [Abstract][Full Text] [Related]
9. Lassa hemorrhagic fever in a late term pregnancy from northern Sierra Leone with a positive maternal outcome: case report. Branco LM; Boisen ML; Andersen KG; Grove JN; Moses LM; Muncy IJ; Henderson LA; Schieffellin JS; Robinson JE; Bangura JJ; Grant DS; Raabe VN; Fonnie M; Zaitsev EM; Sabeti PC; Garry RF Virol J; 2011 Aug; 8():404. PubMed ID: 21843352 [TBL] [Abstract][Full Text] [Related]
11. Geographic distribution and genetic characterization of Lassa virus in sub-Saharan Mali. Safronetz D; Sogoba N; Lopez JE; Maiga O; Dahlstrom E; Zivcec M; Feldmann F; Haddock E; Fischer RJ; Anderson JM; Munster VJ; Branco L; Garry R; Porcella SF; Schwan TG; Feldmann H PLoS Negl Trop Dis; 2013; 7(12):e2582. PubMed ID: 24340119 [TBL] [Abstract][Full Text] [Related]
12. A recombinant vesicular stomatitis virus-based Lassa fever vaccine protects guinea pigs and macaques against challenge with geographically and genetically distinct Lassa viruses. Safronetz D; Mire C; Rosenke K; Feldmann F; Haddock E; Geisbert T; Feldmann H PLoS Negl Trop Dis; 2015 Apr; 9(4):e0003736. PubMed ID: 25884628 [TBL] [Abstract][Full Text] [Related]
13. Lassa fever-induced sensorineural hearing loss: A neglected public health and social burden. Mateer EJ; Huang C; Shehu NY; Paessler S PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006187. PubMed ID: 29470486 [TBL] [Abstract][Full Text] [Related]
14. The Importance of Lassa Fever and Its Disease Management in West Africa. Reyna RA; Littlefield KE; Shehu N; Makishima T; Maruyama J; Paessler S Viruses; 2024 Feb; 16(2):. PubMed ID: 38400041 [TBL] [Abstract][Full Text] [Related]
16. Lassa Fever Natural History and Clinical Management. Grant DS; Samuels RJ; Garry RF; Schieffelin JS Curr Top Microbiol Immunol; 2023; 440():165-192. PubMed ID: 37106159 [TBL] [Abstract][Full Text] [Related]
17. Field evaluation of a Pan-Lassa rapid diagnostic test during the 2018 Nigerian Lassa fever outbreak. Boisen ML; Uyigue E; Aiyepada J; Siddle KJ; Oestereich L; Nelson DKS; Bush DJ; Rowland MM; Heinrich ML; Eromon P; Kayode AT; Odia I; Adomeh DI; Muoebonam EB; Akhilomen P; Okonofua G; Osiemi B; Omoregie O; Airende M; Agbukor J; Ehikhametalor S; Aire CO; Duraffour S; Pahlmann M; Böhm W; Barnes KG; Mehta S; Momoh M; Sandi JD; Goba A; Folarin OA; Ogbaini-Emovan E; Asogun DA; Tobin EA; Akpede GO; Okogbenin SA; Okokhere PO; Grant DS; Schieffelin JS; Sabeti PC; Günther S; Happi CT; Branco LM; Garry RF Sci Rep; 2020 May; 10(1):8724. PubMed ID: 32457420 [TBL] [Abstract][Full Text] [Related]
18. Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs. Maruyama J; Mateer EJ; Manning JT; Sattler R; Seregin AV; Bukreyeva N; Jones FR; Balint JP; Gabitzsch ES; Huang C; Paessler S Vaccine; 2019 Oct; 37(45):6824-6831. PubMed ID: 31561999 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Lassa Fever. Bell-Kareem AR; Smither AR Curr Top Microbiol Immunol; 2023; 440():87-109. PubMed ID: 33861373 [TBL] [Abstract][Full Text] [Related]
20. Monitoring of Lassa virus infection in suspected and confirmed cases in Ondo State, Nigeria. Salu OB; Amoo OS; Shaibu JO; Abejegah C; Ayodeji O; Musa AZ; Idigbe I; Ezechi OC; Audu RA; Salako BL; Omilabu SA Pan Afr Med J; 2020; 36():253. PubMed ID: 33014249 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]